Allamanda Faatoese

University of Otago

The enzyme cytochrome P450 2D6 (CYP2D6) metabolises approximately 25% of commonly prescribed drugs, including analgesics, anti-hypertensives, and anti-depressants, among many others. Genetic variation in drug metabolising genes can alter how an individual responds to prescribed drugs, including predisposing to adverse drug reactions. The majority o...

The enzyme cytochrome P450 2D6 (CYP2D6) metabolises approximately 25% of commonly prescribed drugs, including analgesics, anti-hypertensives, and anti-depressants, among many others. Genetic variation in drug metabolising genes can alter how an individual responds to prescribed drugs, including predisposing to adverse drug reactions. The majority o...

IntroductionNew Zealand health training institutions have an important role in supporting health workforce training programmes in the Pacific Region. AimTo explore the experience of Pacific Island country-based doctors from the Cook Islands, Niue, and Samoa, studying in New Zealand’s University of Otago distance-taught Rural Postgraduate programme....

Aim Pacific Island country (PIC) based doctors have been studying in the New Zealand distance-taught Otago University Rural Postgraduate programme (RPGP) since 2014. The aim of this study was to gain understanding of the experience of these students and their teachers at Otago with focus on strengthening academic support. Methods: The study involv...

Introduction: Pacific Islanders in New Zealand (NZ) have high rates of cardiovascular and metabolic disorders. The Pasifika Heart Study (PHS) recorded ethnic-specific clinical and biomarker data to inform clinical management in community care. Methods: For the PHS, Pacific adults (n=200) aged 20-64 years were selected from patients of a Pacific-led...

Acute rheumatic fever (ARF) is an autoimmune condition caused by untreated Group A Streptococcal (GAS) infection of the upper respiratory tract (and possibly skin). Multiple or severe attacks of ARF can cause cardiac damage, known as Rheumatic Heart Disease (RHD). RHD remains a significant cause of morbidity and mortality is rare in developed count...

Objectives: Cardiovascular disease (CVD) is the leading cause of mortality in New Zealand with a disproportionate burden of disease in the Māori population. The Hauora Manawa Project investigated the prevalence of cardiovascular risk factors and CVD in randomly selected Māori and non-Māori participants. This paper reports the prevalence of structu...

Cardiovascular disease (CVD) is the leading cause of death worldwide. Many indigenous populations are overrepresented among these global statistics. National mortality and morbidity data illustrate that Māori, the indigenous population of New Zealand (NZ), have higher rates of CVD mortality and morbidity than non-Māori, and life expectancy for Māor...

There are few current data on the prevalence of hyperuricaemia and gout in New Zealand, particularly among the indigenous Māori population. To determine the prevalence of gout and hyperuricaemia in rural and urban Māori and non-Māori community samples and describe the treatment and comorbidities of participants with gout. Participants aged 20–64 ye...

To understand health disparities in cardiovascular disease (CVD) in the indigenous Māori of New Zealand, diagnosed and undiagnosed CVD risk factors were compared in rural Māori in an area remote from health services with urban Māori and non-Māori in a city well served with health services. Prospective cohort study. Hauora Manawa is a cohort study o...

To document levels of cardiovascular disease (CVD), diagnosed and undiagnosed risk factors and clinical management of CVD risk in rural Māori. Participants (aged 20-64 years), of Māori descent and self-report, were randomly sampled to be representative of age and gender profiles of the community. Screening clinics included health questionnaires, fa...

To report the processes and protocols that were developed in the design and implementation of the Hauora Manawa Project, a cohort study of heart disease in New Zealand and to report the participation at baseline. This study utilised application of a Kaupapa Māori Methodology in gaining tribal and health community engagement, design of the project a...